-+ 0.00%
-+ 0.00%
-+ 0.00%

AstraZeneca Gefurulimab is approved by the European Union for myasthenia gravis.

Zhitongcaijing·09/18/2026 10:25:05
Listen to the news
AstraZeneca Gefurulimab is approved by the European Union for myasthenia gravis.